Neuland Laboratories Ltd.

View in App
3554.40 -20.05 ▼-0.6%

22 September 2023, 10:39:55 AM
Volume: 7,431

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.neulandlabs.com
Market Cap 4,575.84 Cr.
Enterprise Value(EV) 4,638.25 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 167.91 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 21.24 Trailing Twelve Months Ending 2023-06
Industry PE 37.95 Trailing Twelve Months Ending 2023-06
Book Value / Share 822.35 Trailing Twelve Months Ending 2023-06
Price to Book Value 4.34 Calculated using Price: 3,566.05
Dividend Yield 0.28 Period Ending 2023-03
No. of Shares Subscribed 1.28 Cr. 12,829,889 Shares
FaceValue 10
About Neuland Laboratories Ltd.
Neuland is a quality conscious, research driven, reliable source of active pharmaceutical ingredients. Neuland has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions. Safety aspects have been given utmost significance may it be plant installation, equipment, systems and personnel to ensure smooth productivity. Dedicated team of manufacturing with incorporation of latest production techniques guarantees delivery of latest intermediate and product to our customers across the globe.

Neuland Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Neuland Laboratories Ltd. Performance

View details >>
1 Day
-0.56%
1 Week
-3.52%
1 Month
-6.91%
3 Month
+28.22%
6 Month
+115.74%
1 Year
+148.54%
2 Year
+126.39%
5 Year
+378.29%
10 Year
+1596.77%

Neuland Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 11.24 15.64 22.34 5.02 3.48 2.30 10.79 7.85 17.84
Return on Capital Employed (%) 15.75 18.57 15.98 4.07 3.99 7.85 12.81 9.44 20.94
Return on Assets (%) 3.20 5.23 6.65 1.23 1.49 1.37 6.31 4.71 11.04

Neuland Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 124 161 187 546 558 699 710 786 841 994
Non Curr. Liab. 52 55 69 54 146 104 163 170 180 147
Curr. Liab. 307 295 268 286 367 327 358 369 363 439
Minority Int. 0 0
Equity & Liab. 483 512 524 886 1,071 1,130 1,231 1,325 1,383 1,580
Non Curr. Assets 196 196 210 511 624 677 716 775 803 819
Curr. Assets 288 316 314 375 447 453 515 550 581 761
Misc. Exp. not W/O
Total Assets 483 512 524 886 1,071 1,130 1,231 1,325 1,383 1,580

Neuland Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 469 510 579 527 667 763 937 951 1,191 1,333
Other Income 1 2 1 5 3 4 16 2 10 11
Total Income 470 512 580 532 670 767 953 953 1,201 1,344
Total Expenditure -403 -430 -473 -477 -608 -661 -790 -808 -919 -993
PBIDT 67 82 108 55 62 106 163 145 282 351
Interest -27 -24 -21 -19 -16 -22 -18 -14 -13 -12
Depreciation -15 -16 -19 -22 -26 -31 -40 -49 -53 -54
Taxation -9 -15 -20 -2 -4 -37 -25 -18 -52 -70
Exceptional Items
PAT 16 27 47 12 16 16 81 64 164 215
Minority Interest 0 0
Share Associate
Other Related Items
Consolidated Net Profit 16 27 47 12 16 16 81 64 164 215
Adjusted EPS 18 31 53 14 13 13 63 50 127 167

Neuland Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 49 13 45 39 11 70 57 189 60 237
Cash Fr. Inv. -10 -14 -20 -42 -116 -77 -49 -84 -96 -62
Cash Fr. Finan. -39 1 -24 0 105 12 -5 -114 38 -136
Net Change 0 0 1 -4 0 5 3 -9 3 40
Cash & Cash Eqvt 1 1 2 3 3 8 11 2 5 45

Neuland Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 36.22 36.22 36.22 36.22 36.22 36.22 36.14 36.14 36.03
Public 63.78 63.78 63.78 63.78 63.78 63.78 63.86 63.86 63.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 4.30 4.30 4.30 0.00 0.00 0.00 0.00 0.00 0.00

Neuland Laboratories Ltd. Announcements

View details >>
Wed, 20 Sep 2023
Loss of Share Certificates
Neuland Laboratories Limited has informed the Exchange about Loss of Share Certificates
Thu, 31 Aug 2023
Loss of Share Certificates
Neuland Laboratories Limited has informed the Exchange about Loss of Share Certificates
Wed, 30 Aug 2023
Loss of Share Certificates
Neuland Laboratories Limited has informed the Exchange about Loss of Share Certificates

Neuland Laboratories Ltd. Technical Scans

View details >>
Thu, 21 Sep 2023
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Neuland Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 274,963.79 1,131.10 -1.3%
Divi's Laboratories Ltd. 99,404.71 3,699.10 -1.3%
Cipla Ltd. 97,455.33 1,174.10 -2.7%
Dr. Reddy's Laboratories Ltd. 94,594.48 5,525.25 -2.5%
Apollo Hospitals Enterprise Ltd. 72,171.99 4,987.20 -0.6%
Mankind Pharma Ltd. 69,708.40 1,735.05 -0.3%
Torrent Pharmaceuticals Ltd. 63,451.75 1,838.25 -1.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.67 1,131.10 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 67.23 3,699.10 -1.3%
Cipla Ltd. Consolidated 2023-06 31.32 1,174.10 -2.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 20.07 5,525.25 -2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.04 4,987.20 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 54.38 1,735.05 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.36 1,838.25 -1.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.75 1,131.10 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 7.57 3,699.10 -1.3%
Cipla Ltd. Consolidated 2023-06 4.00 1,174.10 -2.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.86 5,525.25 -2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.52 4,987.20 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,735.05 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.65 1,838.25 -1.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,131.10 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,699.10 -1.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,174.10 -2.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,525.25 -2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 4,987.20 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,735.05 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,838.25 -1.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.10 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,699.10 -1.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,174.10 -2.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,525.25 -2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 4,987.20 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,735.05 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,838.25 -1.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.10 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,699.10 -1.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,174.10 -2.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,525.25 -2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 4,987.20 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,735.05 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,838.25 -1.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,131.10 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,699.10 -1.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,174.10 -2.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,525.25 -2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 4,987.20 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,735.05 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,838.25 -1.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,131.10 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,699.10 -1.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,174.10 -2.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,525.25 -2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 4,987.20 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,735.05 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,838.25 -1.9%

Neuland Laboratories Ltd. FAQ's

What is Neuland Laboratories share price?
Can I buy Neuland Laboratories shares now?
What is the Dividend Yield of Neuland Laboratories?
What is the Market Cap of Neuland Laboratories?
What are the key metrics to analyse Neuland Laboratories?
What is the 52 Week High and Low of Neuland Laboratories?
What is the trend of Neuland Laboratories share price?